157 results · 59ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

CONDUCTIVE TECHNOLOGIES, INC.

FDA registration
CONDUCTIVE TECHNOLOGIES, INC.·2 products·🇺🇸 United States

*

FDA Adverse Event
Malfunction ·WRIGHT MEDICAL TECHNOLOGY, INC.·Product code HWL·November 11, 2004

OPTRELL MAPPING CATHETER WITH TRUEREF TECHNOLOGY

FDA Adverse Event
Malfunction ·BIOSENSE WEBSTER INC·Product code DRF·July 28, 2024

AEH-4 LITHOTRIPSY SYSTEM

FDA Adverse Event
Injury ·NORTHGATE TECHNOLOGIES INC.·Product code FFK·July 10, 2019

WEBSTER ® CS CATHETER WITH EZ STEER® THECHNOLOGY AND AUTO ID

FDA Adverse Event
Injury ·BIOSENSE WEBSTER INC·Product code DRF·February 19, 2020

OPTRELL MAPPING CATHETER WITH TRUEREF TECHNOLOGY

FDA Adverse Event
Injury ·BIOSENSE WEBSTER INC·Product code DRF·May 27, 2025

Xcela PICC Kit with ENDEXO and PASV Valve Technology, XCELA PASV 5F DL 55CM MST-70 Nitinol KIT PG, UPN H965251250, Catalog No. 25-125 The Xcela with PASV, BioFlo PICC with ENDEXO Technology, and BioFlo PICC with ENDEXO and PASV Valve Technology are indicated for short or long-term peripheral access to the central venous system for intravenous therapy, including but not limited to, the administration of fluids, medications, nutrients; the sampling of blood; and for power injection of contrast media. Non-Valve lumens are indicated for central venous pressure monitoring.

FDA Enforcement
Class II ·Terminated·Angiodynamics Inc. (Navilyst Medical Inc.)·December 20, 2017

WEBSTER CS CATHETER WITH AUTO ID TECHNOLOGY

FDA Adverse Event
Injury ·BIOSENSE WEBSTER INC.·Product code LDF·September 26, 2019

WEBSTER ELECTROPHYSIOLOGY CATHETER WITH AUTO ID

FDA Adverse Event
Injury ·BIOSENSE WEBSTER INC.·Product code LDF·September 26, 2019

XCELA PASV 5F DL 55CM MST-70 KIT PG, UPN H965457320, Catalog No. 45-732 The Xcela with PASV, BioFlo PICC with ENDEXO Technology, and BioFlo PICC with ENDEXO and PASV Valve Technology are indicated for short or long-term peripheral access to the central venous system for intravenous therapy, including but not limited to, the administration of fluids, medications, nutrients; the sampling of blood; and for power injection of contrast media. Non-Valve lumens are indicated for central venous pressure monitoring.

FDA Enforcement
Class II ·Terminated·Angiodynamics Inc. (Navilyst Medical Inc.)·December 20, 2017

Bio-Stable 5F DL-55CM MST-70 KIT Non-Valved w/ Nit GW, UPN H965458950, Catalog No. 45-895 The Xcela with PASV, BioFlo PICC with ENDEXO Technology, and BioFlo PICC with ENDEXO and PASV Valve Technology are indicated for short or long-term peripheral access to the central venous system for intravenous therapy, including but not limited to, the administration of fluids, medications, nutrients; the sampling of blood; and for power injection of contrast media. Non-Valve lumens are indicated for central venous pressure monitoring.

FDA Enforcement
Class II ·Terminated·Angiodynamics Inc. (Navilyst Medical Inc.)·December 20, 2017

Bio-Stable 5F DL-55CM MST-70 KIT Non-Valved w/ Nit GW, UPN H965458950, Catalog No. 45-895 The Xcela with PASV, BioFlo PICC with ENDEXO Technology, and BioFlo PICC with ENDEXO and PASV Valve Technology are indicated for short or long-term peripheral access to the central venous system for intravenous therapy, including but not limited to, the administration of fluids, medications, nutrients; the sampling of blood; and for power injection of contrast media. Non-Valve lumens are indicated for central venous pressure monitoring.

FDA Enforcement
Class II ·Terminated·Angiodynamics Inc. (Navilyst Medical Inc.)·December 20, 2017

Bio-Stable 5F SL-55CM IR-145 Kit Valved PG, UPN H965458180, Catalog No. 45-818 The Xcela with PASV, BioFlo PICC with ENDEXO Technology, and BioFlo PICC with ENDEXO and PASV Valve Technology are indicated for short or long-term peripheral access to the central venous system for intravenous therapy, including but not limited to, the administration of fluids, medications, nutrients; the sampling of blood; and for power injection of contrast media. Non-Valve lumens are indicated for central venous pressure monitoring.

FDA Enforcement
Class II ·Terminated·Angiodynamics Inc. (Navilyst Medical Inc.)·December 20, 2017

Bio-Stable 5F DL-55CM MST-70 KIT Non-Valved PG, UPN H965458830, Catalog No. 45-883 The Xcela with PASV, BioFlo PICC with ENDEXO Technology, and BioFlo PICC with ENDEXO and PASV Valve Technology are indicated for short or long-term peripheral access to the central venous system for intravenous therapy, including but not limited to, the administration of fluids, medications, nutrients; the sampling of blood; and for power injection of contrast media. Non-Valve lumens are indicated for central venous pressure monitoring.

FDA Enforcement
Class II ·Terminated·Angiodynamics Inc. (Navilyst Medical Inc.)·December 20, 2017

Bio-Stable 5F DL-55CM MST-70 KIT Non-Valved PG, UPN H965458710, Catalog No. 45-871 The Xcela with PASV, BioFlo PICC with ENDEXO Technology, and BioFlo PICC with ENDEXO and PASV Valve Technology are indicated for short or long-term peripheral access to the central venous system for intravenous therapy, including but not limited to, the administration of fluids, medications, nutrients; the sampling of blood; and for power injection of contrast media. Non-Valve lumens are indicated for central venous pressure monitoring.

FDA Enforcement
Class II ·Terminated·Angiodynamics Inc. (Navilyst Medical Inc.)·December 20, 2017

Bio-Stable 5F DL-55CM IR-145 Kit Valved with Nit GW, UPN H965458890, Catalog No. 45-889 The Xcela with PASV, BioFlo PICC with ENDEXO Technology, and BioFlo PICC with ENDEXO and PASV Valve Technology are indicated for short or long-term peripheral access to the central venous system for intravenous therapy, including but not limited to, the administration of fluids, medications, nutrients; the sampling of blood; and for power injection of contrast media. Non-Valve lumens are indicated for central venous pressure monitoring.

FDA Enforcement
Class II ·Terminated·Angiodynamics Inc. (Navilyst Medical Inc.)·December 20, 2017

XCELA PASV 5F DL 55CM IR-145 Nitinol Wire KIT PG, UPN H965251260, Catalog No. 25-126 The Xcela with PASV, BioFlo PICC with ENDEXO Technology, and BioFlo PICC with ENDEXO and PASV Valve Technology are indicated for short or long-term peripheral access to the central venous system for intravenous therapy, including but not limited to, the administration of fluids, medications, nutrients; the sampling of blood; and for power injection of contrast media. Non-Valve lumens are indicated for central venous pressure monitoring.

FDA Enforcement
Class II ·Terminated·Angiodynamics Inc. (Navilyst Medical Inc.)·December 20, 2017

Bio-Stable 5F DL-55CM IR-145 Kit Valved PG, UPN H965458330, Catalog No. 45-833 The Xcela with PASV, BioFlo PICC with ENDEXO Technology, and BioFlo PICC with ENDEXO and PASV Valve Technology are indicated for short or long-term peripheral access to the central venous system for intravenous therapy, including but not limited to, the administration of fluids, medications, nutrients; the sampling of blood; and for power injection of contrast media. Non-Valve lumens are indicated for central venous pressure monitoring.

FDA Enforcement
Class II ·Terminated·Angiodynamics Inc. (Navilyst Medical Inc.)·December 20, 2017

Bio-Stable 5F DL-55CM MST-70 KIT Non-Valved w/ Nit GW, UPN H965458950, Catalog No. 45-895 The Xcela with PASV, BioFlo PICC with ENDEXO Technology, and BioFlo PICC with ENDEXO and PASV Valve Technology are indicated for short or long-term peripheral access to the central venous system for intravenous therapy, including but not limited to, the administration of fluids, medications, nutrients; the sampling of blood; and for power injection of contrast media. Non-Valve lumens are indicated for central venous pressure monitoring.

FDA Enforcement
Class II ·Terminated·Angiodynamics Inc. (Navilyst Medical Inc.)·December 20, 2017

Bio-Stable 5F DL-55CM MST-70 KIT Non-Valved PG, UPN H965458710, Catalog No. 45-871 The Xcela with PASV, BioFlo PICC with ENDEXO Technology, and BioFlo PICC with ENDEXO and PASV Valve Technology are indicated for short or long-term peripheral access to the central venous system for intravenous therapy, including but not limited to, the administration of fluids, medications, nutrients; the sampling of blood; and for power injection of contrast media. Non-Valve lumens are indicated for central venous pressure monitoring.

FDA Enforcement
Class II ·Terminated·Angiodynamics Inc. (Navilyst Medical Inc.)·December 20, 2017